WinstonWınston
IDenta logo

IDenta

IDTA
56
Medical - Specialties · Healthcare
Price
$0.22
-0.03 (-12.00%)
Market Cap
$890,030
Winston Score
56
Winston is curious
A decent business — some strong pillars, some weaker.

Share count rising — dilution

+16.6% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 4.0M (2021) → 4.7M (2025)

IDenta Corp. is a small diagnostics company that makes rapid identification tests. Its core products are portable testing kits used to detect substances — including drugs and explosives — quickly in the field without needing a laboratory. Its main customers are law enforcement agencies, border security forces, and government organizations that need fast, on-the-spot results.

The company earns revenue by selling its testing kits and related consumables directly to government and security customers, primarily in Israel and select international markets. IDenta operates at a small scale, but its focused niche in field-ready detection tools gives it a degree of specialization that larger diagnostics companies do not prioritize. The key growth driver is expanding sales to new government and law enforcement customers internationally, while the main risk is its heavy dependence on a narrow customer base and the potential for budget cuts in public-sector security spending to reduce demand.

Winston Score History

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
70.5%
Premium pricing power — 70.5% gross margin
Operating Margin
33.2%
Excellent — 33.2% operating margin
ROCE
9.8%
Below par — 9.8% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-7.9%
Shrinking sales (-7.9% YoY)
EPS YoY
-62.8%
Earnings shrinking (-62.8% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
57%
Weak — only 57% of profit becomes cash
FCF Margin
3.0%
Thin free cash flow (3.0%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.53
Conservative — low debt load (0.53)
Interest Cover
18.57x
Comfortably covers interest (18.6x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
9.0x
Attractive valuation — P/E 9.0

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial